GlobeNewswire Inc | Aug 4, 2021 07:00AM EDT

August 04, 2021

SINGAPORE, Aug. 04, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on August 9, 2021, at 09:00 am ET. The conference will be held from August 9 to August 10, 2021.

Media and IR contacts

Emma Thompson Ashley R. RobinsonSpurwing Communications LifeSci Advisors, LLCTel: +65 6206 7350 Tel: +1 (617) 430-7577Email: ASLAN@spurwingcomms.com Email: arr@lifesciadvisors.com

About ASLAN PharmaceuticalsASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLANis currently evaluatingASLAN004, apotential first-in-classantibodytargeting the IL-13 receptor,in atopic dermatitis, and ASLAN003,apotent oralinhibitorofDHODH, which is being developed forautoimmune disease.ASLAN has a team in the Bay Area and in Singapore.For additional information please visitwww.aslanpharma.comor followASLANon LinkedIn.